Many U.S. children eligible for type 2 diabetes screening

Many U.S. children eligible for type 2 diabetes screening

(HealthDay)—Many children are eligible for type 2 diabetes screening, but few test positive for prediabetes or diabetes, according to a study published online Aug. 10 in Pediatrics.

Amelia S. Wallace, from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues conducted a involving 14,119 youth aged 10 to 19 years in the 1999 to 2016 National Health and Nutrition Examination Survey. The authors evaluated the performance of the American Diabetes Association risk-based screening criteria, as well as the performance of current clinical definitions of prediabetes and diabetes based on hemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) for identifying high cardiometabolic risk.

The researchers found that 25.5 percent of U.S. youth were eligible for screening. The and specificity of the screening criteria for detecting any hyperglycemia were low for HbA1c ≥5.7 percent (55.5 and 76.3 percent, respectively) and FPG ≥100 mg/dL (35.8 and 77.1 percent, respectively). Confirmed undiagnosed diabetes was seen rarely (<0.5 percent of youth). More than 85 percent of diabetes cases were diagnosed. Consistently stronger and more specific associations with cardiometabolic risk were seen for HbA1c-defined hyperglycemia (specificity, 98.6 percent; sensitivity, 4.0 percent) than with FPG-defined hyperglycemia (specificity, 90.1 percent; sensitivity, 19.4 percent).

"The current screening approach targets a large number of children and adolescents, whereas few will test positive for diabetes or prediabetes, and a substantial number of children with hyperglycemia may be missed," the authors write.

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Journal information: Pediatrics

Copyright © 2020 HealthDay. All rights reserved.

Citation: Many U.S. children eligible for type 2 diabetes screening (2020, August 10) retrieved 25 July 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

2019 screening guidelines would label more as T2DM cases


Feedback to editors